Phase 3 Partial Epilepsy Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study to Evaluate the Safety, Efficacy, and PK of ONO-2017 in Japanese Patients With POS 2 to 17 Year Olds
Partial Epilepsy
Ono Pharmaceutical Co., Ltd.20 enrolled1 locationNCT07594158
Completed
Phase 3
Efficacy & Safety of Zonisamide in newly diagnosed partial epilepsy patients.
Newly diagnosed partial epilepsy
Eisai Ltd582 enrolled1 locationACTRN12607000142437